Effects of Single α-to-β Residue Replacements on Recognition of an Extended Segment in a Viral Fusion Protein.


Journal

ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580

Informations de publication

Date de publication:
14 08 2020
Historique:
pubmed: 22 7 2020
medline: 24 6 2021
entrez: 22 7 2020
Statut: ppublish

Résumé

Partial replacement of α-amino acid residues with β-amino acid residues has been established as a strategy for preserving target-engagement by helix-forming polypeptides while altering other properties. The impact of β-residue incorporation within polypeptides that adopt less regular conformations, however, has received less attention. The C-terminal heptad repeat (HRC) domains of fusion glycoproteins from pathogenic paramyxoviruses contain a segment that must adopt an extended conformation in order to coassemble with the N-terminal heptad repeat (HRN) domain in the postfusion state and drive a merger of the viral envelope with a target cell membrane. Here, we examine the impact of single α-to-β substitutions within this extended N-terminal segment of an engineered HRC peptide designated VIQKI. Stabilities of hexameric coassemblies formed with the native human parainfluenza virus 3 (HPIV3) HRN have been evaluated, the structures of five coassemblies have been determined, and antiviral efficacies have been measured. Many sites within the extended segment show functional tolerance of α-to-β substitution. These results offer a basis for future development of paramyxovirus infection inhibitors with novel biological activity profiles, possibly including resistance to proteolysis.

Identifiants

pubmed: 32692914
doi: 10.1021/acsinfecdis.0c00385
pmc: PMC8019249
mid: NIHMS1676307
doi:

Substances chimiques

Antiviral Agents 0
Peptides 0
Viral Fusion Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2017-2022

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM061238
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI114736
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008349
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI121349
Pays : United States
Organisme : NIGMS NIH HHS
ID : F32 GM122263
Pays : United States

Références

Nat Commun. 2014;5:3067
pubmed: 24473083
Nature. 1989 Nov 16;342(6247):296-9
pubmed: 2812029
J Pediatr. 2009 May;154(5):694-9
pubmed: 19159905
Sci Adv. 2019 Apr 10;5(4):eaav4580
pubmed: 30989115
Nat Biotechnol. 2014 Jul;32(7):653-5
pubmed: 24929976
Lancet. 2010 May 1;375(9725):1545-55
pubmed: 20399493
J Am Chem Soc. 2011 Jul 6;133(26):10038-41
pubmed: 21644542
J Am Chem Soc. 2012 Jan 11;134(1):315-23
pubmed: 22040025
Nat Chem. 2013 Mar;5(3):161-73
pubmed: 23422557
J Immunol. 2005 Sep 15;175(6):3810-8
pubmed: 16148127
J Am Chem Soc. 2020 Feb 5;142(5):2140-2144
pubmed: 31951396
Nat Chem Biol. 2007 May;3(5):252-62
pubmed: 17438550
Org Biomol Chem. 2018 Oct 31;16(42):7878-7882
pubmed: 30306175
ACS Chem Biol. 2015 Jul 17;10(7):1667-75
pubmed: 25946900
Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4552-7
pubmed: 25825775
J Biol Chem. 2001 Jul 6;276(27):24525-30
pubmed: 11342555
Drug Discov Today. 2015 Jan;20(1):122-8
pubmed: 25450771
Annu Rev Virol. 2014 Nov;1(1):171-89
pubmed: 26958720
Adv Drug Deliv Rev. 2017 Dec 1;122:2-19
pubmed: 27916504
J Immunol. 2019 Sep 15;203(6):1619-1628
pubmed: 31391235
J Am Chem Soc. 2006 Jul 19;128(28):9248-56
pubmed: 16834399
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14751-6
pubmed: 19706443
mBio. 2020 Feb 11;11(1):
pubmed: 32047132
Angew Chem Int Ed Engl. 2015 Mar 2;54(10):2960-5
pubmed: 25651514
Virology. 2005 May 10;335(2):276-85
pubmed: 15840526
J Am Chem Soc. 2012 May 2;134(17):7317-20
pubmed: 22524614
Curr Opin Chem Biol. 2008 Dec;12(6):692-7
pubmed: 18793750
Bioorg Med Chem. 2018 Jun 1;26(10):2700-2707
pubmed: 28720325
J Med Chem. 2018 Feb 22;61(4):1382-1414
pubmed: 28737935
J Am Chem Soc. 2014 Sep 17;136(37):12848-51
pubmed: 25191938
Chem Commun (Camb). 2019 Dec 5;55(98):14809-14812
pubmed: 31763628
Org Lett. 2015 Jul 17;17(14):3524-7
pubmed: 26153619
Chembiochem. 2013 Sep 2;14(13):1564-72
pubmed: 23929624
J Neurosci. 2015 Dec 16;35(50):16463-78
pubmed: 26674871
Nat Struct Mol Biol. 2008 Jul;15(7):690-8
pubmed: 18596815
Viruses. 2012 Apr;4(4):613-36
pubmed: 22590688
J Am Chem Soc. 2002 May 8;124(18):4972-3
pubmed: 11982357
J Am Chem Soc. 2019 Aug 14;141(32):12648-12656
pubmed: 31268705
J Med Chem. 2000 Oct 5;43(20):3803-8
pubmed: 11020297
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9288-93
pubmed: 15964978

Auteurs

Victor K Outlaw (VK)

Department of Chemistry, University of Wisconsin, Madison, Wisconsin 53706, United States.

Dale F Kreitler (DF)

Department of Chemistry, University of Wisconsin, Madison, Wisconsin 53706, United States.

Debora Stelitano (D)

Department of Pediatrics, Columbia University Medical Center, New York, New York 10032, United States.
Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York 10032, United States.
Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.

Matteo Porotto (M)

Department of Pediatrics, Columbia University Medical Center, New York, New York 10032, United States.
Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York 10032, United States.
Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.

Anne Moscona (A)

Department of Pediatrics, Columbia University Medical Center, New York, New York 10032, United States.
Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York 10032, United States.
Department of Microbiology & Immunology, Columbia University Medical Center, New York, New York 10032, United States.
Department of Physiology & Cellular Biophysics, Columbia University Medical Center, New York, New York 10032, United States.

Samuel H Gellman (SH)

Department of Chemistry, University of Wisconsin, Madison, Wisconsin 53706, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH